Dec. 9, 2025
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference